Yukinori Matsuo

researcher

Born 2000-01-01

Yukinori Matsuo is …
instance of (P31):
humanQ5

External links are
P11496CiNii Research ID1420282801190687104
P9776e-Rad researcher number80456897
P7783J-GLOBAL ID201401093071290618
P3835Mendeley person IDyukinori-matsuo
P496ORCID iD0000-0002-4372-8259
P3829Publons author ID533972
P1053ResearcherIDO-6200-2014
P5029Researchmap IDMatsuoY
P1153Scopus author ID9239837700

P69educated atKyoto UniversityQ336264
P108employerKyoto UniversityQ336264
Kindai UniversityQ912329
P734family nameMatsuoQ24090443
MatsuoQ24090443
MatsuoQ24090443
P735given nameYukinoriQ8060732
YukinoriQ8060732
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q88554784A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence
Q58757348A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer
Q48668589A multi-centre analysis of treatment procedures and error components in dynamic tumour tracking radiotherapy
Q55114654A promising result of locoregional tumor control with biologically adaptive radiotherapy in patients with locally advanced non-small cell lung cancer.
Q61446067A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy
Q53652716Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy.
Q38721317Assessment of treatment response after lung stereotactic body radiotherapy using diffusion weighted magnetic resonance imaging and positron emission tomography: A pilot study
Q48664378Baseline correction of a correlation model for improving the prediction accuracy of infrared marker-based dynamic tumor tracking
Q57150774Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
Q37739617Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer
Q64325948Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database
Q45157055Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame
Q51476255Comparative evaluation of respiratory-gated and ungated FDG-PET for target volume definition in radiotherapy treatment planning for pancreatic cancer.
Q85676396Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis
Q92521387Comparison of radiomic features in diagnostic CT images with and without contrast enhancement in the delayed phase for NSCLC patients
Q36767669Current status of stereotactic body radiotherapy for lung cancer
Q39702333Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol
Q36210612Development of a four-axis moving phantom for patient-specific QA of surrogate signal-based tracking IMRT.
Q36285058Development of a four-dimensional Monte Carlo dose calculation system for real-time tumor-tracking irradiation with a gimbaled X-ray head
Q34514441Differences in dose-volumetric data between the analytical anisotropic algorithm and the x-ray voxel Monte Carlo algorithm in stereotactic body radiation therapy for lung cancer
Q36661346Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer
Q38801355Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer
Q53178520Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer.
Q44406043Dosimetric comparison of Acuros XB, AAA, and XVMC in stereotactic body radiotherapy for lung cancer
Q39395497Dosimetric comparison of lung stereotactic body radiotherapy treatment plans using averaged computed tomography and end-exhalation computed tomography images: Evaluation of the effect of different dose-calculation algorithms and prescription methods
Q50875685Dosimetric evaluation of the Acuros XB algorithm for a 4 MV photon beam in head and neck intensity-modulated radiation therapy.
Q42321832Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
Q43804177Dosimetric impact of gold markers implanted closely to lung tumors: a Monte Carlo simulation
Q83190161Dosimetric investigation of breath-hold intensity-modulated radiotherapy for pancreatic cancer
Q48652169Dynamic tumor-tracking radiotherapy with real-time monitoring for liver tumors using a gimbal mounted linac
Q99239159Dynamic tumor-tracking stereotactic body radiation therapy for a solitary tumor in a transplanted organ: two case reports
Q51794979Effect of audio coaching on correlation of abdominal displacement with lung tumor motion.
Q51164177Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a new treatment planning method.
Q51286974Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer.
Q59335153Evaluation of Dynamic Tumor-tracking Intensity-modulated Radiotherapy for Locally Advanced Pancreatic Cancer
Q47356300Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.
Q50610138Evaluation of dynamic tumour tracking radiotherapy with real-time monitoring for lung tumours using a gimbal mounted linac.
Q53459469Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors.
Q38842046Evaluation of the prevalence of burnout and psychological morbidity among radiation oncologist members of the Kyoto Radiation Oncology Study Group (KROSG).
Q51578417Experimental validation of heterogeneity-corrected dose-volume prescription on respiratory-averaged CT images in stereotactic body radiotherapy for moving tumors.
Q57058757Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702)
Q53391674Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe.
Q36833711Guidelines for respiratory motion management in radiation therapy
Q84880388Hyperfractionated irradiation with 3 cycles of induction chemotherapy in stage IIIA-N2 lung cancer
Q91018881Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer
Q88740973Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer
Q43515856Impact of motion velocity on four-dimensional target volumes: a phantom study
Q38265753Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer
Q36373998Impact of sampling interval in training data acquisition on intrafractional predictive accuracy of indirect dynamic tumor-tracking radiotherapy.
Q48533010Influence of the correlation modeling period on the prediction accuracy of infrared marker-based dynamic tumor tracking using a gimbaled X-ray head
Q36851015Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc.
Q85639610Interfraction variation in lung tumor position with abdominal compression during stereotactic body radiotherapy
Q45128988Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer
Q43910024Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy
Q83863655Interfractional reproducibility in pancreatic position based on four-dimensional computed tomography
Q51919778Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer.
Q48886961Intra- and interfractional variations in geometric arrangement between lung tumours and implanted markers
Q39207321Intrafractional tracking accuracy in infrared marker-based hybrid dynamic tumour-tracking irradiation with a gimballed linac.
Q33645887Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients
Q33438674Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma
Q47174044Measurement of interfraction variations in position and size of target volumes in stereotactic body radiotherapy for lung cancer
Q36843349Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study
Q48621432Multivariate analysis for the estimation of target localization errors in fiducial marker-based radiotherapy
Q45762954New algorithm to simulate organ movement and deformation for four-dimensional dose calculation based on a three-dimensional CT and fluoroscopy of the thorax
Q48762839Optimization of the x-ray monitoring angle for creating a correlation model between internal and external respiratory signals
Q52381358Optimization of training periods for the estimation model of three-dimensional target positions using an external respiratory surrogate.
Q48202266Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1).
Q39087641Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV⩾100cc
Q40669964Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702).
Q82467952Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer
Q49579195Pilot Study of the Safety and Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumors
Q37787415Positional Reproducibility of Pancreatic Tumors Under End-Exhalation Breath-Hold Conditions Using a Visual Feedback Technique
Q53053644Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET.
Q39355265Predictive uncertainty in infrared marker-based dynamic tumor tracking with Vero4DRT.
Q54281644Preliminary Analysis of Pretreatment Diffusion-Weighted MRI and (18)F-FDG PET/CT as Prognostic Factors in Patients With Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy.
Q83263602Preliminary report of late recurrences, at 5 years or more, after stereotactic body radiation therapy for non-small cell lung cancer
Q35661919Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
Q47857798Prognostic Significance of Serum CEA for Non-small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy
Q51565476Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.
Q48504249Quantification of the kV X-ray imaging dose during real-time tumor tracking and from three- and four-dimensional cone-beam computed tomography in lung cancer patients using a Monte Carlo simulation
Q45052957Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable prognosis
Q43597863Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx
Q38777891SU-E-J-142: Gafchromic Film Dosimetry in Fluoroscopy for Dynamic Tumor Tracking Irradiation of the Lung Using XR-SP2 Model - A Phantom Study.
Q44555068Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation
Q88149536Salvage Pulmonary Metastasectomy for Local Relapse After Stereotactic Body Radiotherapy
Q51742335Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients.
Q64081408Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer
Q57764566Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study
Q79421790Stereotactic body radiation therapy (SBRT) for early-stage lung cancer
Q50697411Stereotactic body radiation therapy for lung cancer: achievements and perspectives.
Q93064494Stereotactic body radiotherapy as an alternative to metastasectomy for pulmonary oligometastasis
Q80976956Stereotactic body radiotherapy for oligometastatic lung tumors
Q90087984Surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer: review of meta-analyses
Q84524583Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group
Q35591817Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma
Q48661723Target localization errors from fiducial markers implanted around a lung tumor for dynamic tumor tracking
Q39430055Technical Note: Introduction of variance component analysis to setup error analysis in radiotherapy
Q51124161The accuracy of extracted target motion trajectories in four-dimensional cone-beam computed tomography for lung cancer patients.
Q34366525The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer
Q50802046Transurethral coil embolization for the management of ureteroarterial fistula: a case report.
Q40596060Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer: Importance of Salvage Surgery.
Q91896990Tumour volume comparison between 16-row multi-detector computed tomography and 320-row area-detector computed tomography in patients with small lung tumours treated with stereotactic body radiotherapy: Effect of respiratory motion
Q47745150Use of a second-dose calculation algorithm to check dosimetric parameters for the dose distribution of a first-dose calculation algorithm for lung SBRT plans.
Q45003519Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer
Q83150533[Stereotactic body radiotherapy (SBRT)]

Search more.